cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Pacific Biosciences Of California Inc
85 own
48 watching
Current Price
$1.74
$-0.11
(-5.95%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
463.3M
52-Week High
52-Week High
7.5
52-Week Low
52-Week Low
1.16000
Average Volume
Average Volume
32.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
148.4118
iconMarket Capitalization463.3M
icon52-Week High7.5
icon52-Week Low1.16000
iconAverage Volume32.06M
iconDividend Yield--
iconP/E Ratio148.4118
What does the Pacific Biosciences Of California Inc do?
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company's single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. It offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes biochemical sequencing reactions. The company also provides consumable products, including SMRT cells, as well as various reagent kits, such as template preparation, binding, and sequencing kits. Its customers include research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. The company markets its products through a direct sales force in North America and Europe, as well as primarily through distributors in Asia, the Middle East, and Latin America. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.
Read More
How much money does Pacific Biosciences Of California Inc make?
News & Events about Pacific Biosciences Of California Inc.
PR Newswire
1 year ago
PacBio Announces New Nanobind Extraction Kits to Enable High-Throughput Workflows with Revio and Sequel Systems PacBio Announces New Nanobind Extraction Kits to Enable High-Throughput Workflows with Revio and Sequel Systems PR Newswire MENLO Park, Calif., April 5, 2023 Kits Combine the Power of...
Market News Video
1 year ago
In trading on Friday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 5.3% on the day. Components of that ETF showing particular strength include shares of Pacific Biosciences of California, up about 17.9% and shares of Personalis, up about 16.5% on the day...
Invezz News
1 year ago
Pacific Biosciences of California Inc (NASDAQ: PACB) is trading meaningfully up on Friday after a TD Cowen analyst turned super bullish on the biotechnology company. Pacific Biosciences stock has upside to $15 Dan Brennan now rates the said biotech stock at outperform. He raised his ...
PR Newswire
1 year ago
PacBio and Corteva Agriscience Enable Groundbreaking Plant and Microbial Long-Read Sequencing Workflow on Revio System PacBio and Corteva Agriscience Enable Groundbreaking Plant and Microbial Long-Read Sequencing Workflow on Revio System PR Newswire MENLO PARK, Calif., March 28, 2023 MENLO PARK...
PR Newswire
1 year ago
PacBio to Present at Cowen's 43rd Annual Health Care Conference PacBio to Present at Cowen's 43rd Annual Health Care Conference PR Newswire MENLO PARK, Calif., Feb. 27, 2023 MENLO PARK, Calif., Feb. 27, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate...
Frequently Asked Questions
Frequently Asked Questions
What is Pacific Biosciences Of California Inc share price today?
plus_minus_icon
Can Indians buy Pacific Biosciences Of California Inc shares?
plus_minus_icon
How can I buy Pacific Biosciences Of California Inc shares from India?
plus_minus_icon
Can Fractional shares of Pacific Biosciences Of California Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Pacific Biosciences Of California Inc stocks?
plus_minus_icon
What is today’s traded volume of Pacific Biosciences Of California Inc?
plus_minus_icon
What is today’s market capitalisation of Pacific Biosciences Of California Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Pacific Biosciences Of California Inc?
plus_minus_icon
What percentage is Pacific Biosciences Of California Inc down from its 52-Week High?
plus_minus_icon
What percentage is Pacific Biosciences Of California Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.74
$-0.11
(-5.95%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Kura Oncology Inc
Kura Oncology Inc
$7.24
$-0.02 (-0.27 %)
Vericel Corporation
Vericel Corporation
$57.49
$-1.18 (-2.01 %)
Mesoblast
Mesoblast
$17.11
$0.13 (0.77 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$11.31
$0.84 (8.02 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Kura Oncology Inc
Kura Oncology Inc
$7.24
$-0.02 (-0.27 %)
Vericel Corporation
Vericel Corporation
$57.49
$-1.18 (-2.01 %)
Mesoblast
Mesoblast
$17.11
$0.13 (0.77 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$11.31
$0.84 (8.02 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00